Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits

Biochimie

Volumn 91, Issue 2, 2009, Pages 261-270

  Winiarska, Katarzyna ^a   Szymanski, Konrad ^a   Gorniak, Patryk ^a   Dudziak, Marta ^a   Bryla, Jadwiga ^a  

^a UNIVERSITY OF WARSAW   (Poland)

Author keywords

Diabetes; Diabetes treatment; Nephropathy; Oxidative stress; Taurine

Indexed keywords

ALBUMINURIA; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CATALASE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GLUCONEOGENESIS; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYPOGLYCEMIC AGENTS; KIDNEY CORTEX; MALE; NADP; OXIDATION-REDUCTION; OXIDATIVE STRESS; RABBITS; SUPEROXIDE DISMUTASE; SUPEROXIDES; TAURINE; UREA;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 58549084764     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.09.006     Document Type: Article

References (73)

1. Brosnan J.T., and Brosnan M.E. The sulfur-containing amino acids: an overview. J. Nutr. 136 (2006) 1636S-1640S
2. Sturman J.A. Taurine in development. Physiol. Rev. 73 (1993) 119-147
3. Schuller-Levis G.B., and Park E. Taurine: new implications for an old amino acid. FEMS. Microbiol. Lett. 226 (2003) 195-202
4. Ito T., Kimura Y., Uozumi Y., Takai M., Muraoka S., Matsuda T., Ueki K., Yoshiyama M., Ikawa M., Okabe M., Schaffer S.W., Fujio Y., and Azuma J. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J. Mol. Cell. Cardiol. 44 (2008) 927-937
5. Schaffer S.W., Lombardini J.B., and Azuma J. Interaction between the actions of taurine and angiotensin II. Amino. Acids. 18 (2000) 305-318
6. Franconi F., Di Leo M.A., Bennardini F., and Ghirlanda G. Is taurine beneficial in reducing risk factors for diabetes mellitus?. Neurochem. Res. 29 (2004) 143-150
7. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
8. Stevens M.J. Redox-based mechanisms in diabetes. Antioxid. Redox. Signal. 7 (2005) 1483-1485
9. Gill P.S., and Wilcox C.S. NADPH oxidases in the kidney. Antioxid. Redox. Signal. 8 (2006) 1597-1607
10. Bryla J., Kiersztan A., and Jagielski A.K. Promising novel approaches to diabetes mellitus therapy: pharmacological, molecular and cellular insights. Eur. Citizen's. Qual. Life. 1 (2003) 137-161
11. Franconi F., Loizzo A., Ghirlanda G., and Seghieri G. Taurine supplementation and diabetes mellitus. Curr. Opin. Clin. Nutr. Metab. Care. 9 (2006) 32-36
12. Usatenko M.S. Hormonal regulation of phosphoenolpyruvate carboxykinase activity in liver and kidney of adult animals and formation of this enzyme in developing rabbit liver. Biochem. Med. 3 (1970) 298-310
13. Kiersztan A., Modzelewska A., Jarzyna R., and Bryla J. Inhibition of gluconeogenesis by vanadium and metformin in kidney cortex tubules isolated from control and diabetic rabbits. Biochem. Pharmacol. 63 (2002) 1371-1382
14. McCabe D.R., Maher T.J., and Acworth I.N. Improved method for the estimation of hydroxyl free radical levels in vivo based on liquid chromatography with electrochemical detection. J. Chromatogr. B. Biomed. Sci. Appl. 691 (1997) 23-32
15. Dincer Y., Akcay T., Alademir Z., and Ilkova H. Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutat. Res. 505 (2002) 75-81
16. Winiarska K., Drozak J., Wegrzynowicz M., Jagielski A.K., and Bryla J. Relationship between gluconeogenesis and glutathione redox state in rabbit kidney cortex tubules. Metabolism 52 (2003) 739-746
17. McLellan L.I., Kerr L.A., Cronshaw A.D., and Hayes J.D. Regulation of mouse glutathione S-transferases by chemoprotectors. Molecular evidence for the existence of three distinct alpha-class glutathione S-transferase subunits, Ya1, Ya2, and Ya3, in mouse liver. Biochem. J. 276 (1991) 461-469
18. Chen Y., Gill P.S., and Welch W.J. Oxygen availability limits renal NADPH-dependent superoxide production. Am. J. Physiol. Renal. Physiol. 289 (2005) F749-F753
19. Jarzyna R., Kiersztan A., Lisowa O., and Bryła J. The inhibition of gluconeogenesis by chloroquine contributes to its hypoglycaemic action. Eur. J. Pharmacol. 428 (2001) 381-388
20. Kim H.G., Hong S.M., Kim S.J., Park H.J., Jung H.I., Lee Y.Y., Moon J.S., Lim H.W., Park E.H., and Lim C.J. Age-related changes in the activity of antioxidant and redox enzymes in rats. Mol. Cell. 16 (2003) 278-284
21. Bergmeyer H.U. Methods in Enzymatic Analysis (1983), Verlag Chemie GmbH, Weinheim- Basel
22. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70 (1967) 158-169
23. Hamilton D., Wu J.H., Alaoui-Jamali M., and Batist G. A novel missense mutation in the gamma-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production. Blood 102 (2003) 725-730
24. Gorin Y., Block K., Hernandez J., Bhandari B., Wagner B., Barnes J.L., and Abboud H.E. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J. Biol. Chem. 280 (2005) 39616-39626
25. Cheng F.C., Jen J.F., and Tsai T.H. Hydroxyl radical in living systems and its separation methods. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 781 (2002) 481-496
26. Chang J.Y., Knecht R., and Braun D.G. Amino acid analysis in the picomole range by precolumn derivatization and high-performance liquid chromatography. Meth. Enzymol. 91 (1983) 41-48
27. DA Fonseca-Wollheim F., and Heinze K.G. The influence of pCO2 on the rate of ammonia formation in blood. Eur. J. Clin. Chem. Clin. Biochem. 30 (1992) 867-869
28. Michalik M., Biedermann I., Lietz T., and Bryla J. Recovery of impaired gluconeogenesis in kidney cortex tubules of gentamicin-treated rabbits. Pharm. Res. 23 (1991) 259-269
29. Ridnour L.A., Winters R.A., Ercal N., and Spitz D.R. Measurement of glutathione, glutathione disulfide, and other thiols in mammalian cell and tissue homogenates using high-performance liquid chromatography separation of N-(1-pyrenyl)maleimide derivatives. Meth. Enzymol. 299 (1991) 258-267
30. Layne E. Spectrophotometric and turbidimetric methods for measuring protein. In: Colowick S.P., and Kaplan N.O. (Eds). Meth. Enzymol. (1957), Academic Press, New York 447-454
31. Franconi F., Bennardini F., Mattana A., Miceli M., Ciuti M., Mian M., Gironi A., Anichini R., and Seghieri G. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am. J. Clin. Nutr. 61 (1995) 1115-1119
32. De Luca G., Calpona P.R., Caponetti A., Romano G., Di Benedetto A., Cucinotta D., and Di Giorgio R.M. Taurine and osmoregulation: platelet taurine content, uptake, and release in type 2 diabetic patients. Metabolism 50 (2001) 60-64
33. Pop-Busui R., Sullivan K.A., Van Huysen C., Bayer L., Cao X., Towns R., and Stevens M.J. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits. Exp. Neurol. 168 (2001) 259-272
34. Colivicchi M.A., Raimondi L., Bianchi L., Tipton K.F., Pirisino R., and Della Corte L. Taurine prevents streptozotocin impairment of hormone-stimulated glucose uptake in rat adipocytes. Eur. J. Pharmacol. 495 (2004) 209-215
35. Tenner Jr. T.E., Zhang X.J., and Lombardini J.B. Hypoglycemic effects of taurine in the alloxan-treated rabbit, a model for type 1 diabetes. Adv. Exp. Med. Biol. 526 (2003) 97-104
36. Nakaya Y., Minami A., Harada N., Sakamoto S., Niwa Y., and Ohnaka M. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am. J. Clin. Nutr. 71 (2000) 54-58
37. Franconi F., Santini S.A., Gentiloni Silveri N., Caputo S., Giardina B., Ghirlanda G., and Di Leo M.A. Taurine reduces mortality in diabetic rats: taurine and experimental diabetes mellitus. Adv. Exp. Med. Biol. 526 (2003) 67-73
38. Di Leo M.A., Santini S.A., Silveri N.G., Giardina B., Franconi F., and Ghirlanda G. Long-term taurine supplementation reduces mortality rate in streptozotocin-induced diabetic rats. Amino. Acids. 27 (2004) 187-191
39. Nandhini A.T., Thirunavukkarasu V., and Anuradha C.V. Stimulation of glucose utilization and inhibition of protein glycation and AGE products by taurine. Acta. Physiol. Scand. 181 (2004) 297-303
40. Obrosova I.G., Minchenko A.G., Marinescu V., Fathallah L., Kennedy A., Stockert C.M., Frank R.N., and Stevens M.J. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 44 (2001) 1102-1110
41. Li F., Obrosova I.G., Abatan O., Tian D., Larkin D., Stuenkel E.L., and Stevens M.J. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E29-E36
42. Li F., Abatan O.I., Kim H., Burnett D., Larkin D., Obrosova I.G., and Stevens M.J. Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats. Neurobiol. Dis. 22 (2006) 669-676
43. Haber C.A., Lam T.K., Yu Z., Gupta N., Goh T., Bogdanovic E., Giacca A., and Fantus I.G. N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E744-E753
44. Kim H.W., Lee A.J., You S., Park T., and Lee D.H. Characterization of taurine as inhibitor of sodium glucose transporter. Adv. Exp. Med. Biol. 583 (2006) 137-145
45. Gerich J.E., Meyer C., Woerle H.J., and Stumvoll M. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes. Care. 24 (2001) 382-391
46. Jagielski A.K., Wohner D., Lietz T., Jarzyna R., Derlacz R.A., Winiarska K., and Bryla J. Purinergic regulation of glucose and glutamine synthesis in isolated rabbit kidney-cortex tubules. Arch. Biochem. Biophys. 404 (2002) 186-196
47. Kiersztan A., Winiarska K., Drozak J., Przedlacka M., Wegrzynowicz M., Fraczyk T., and Bryla J. Differential effects of vanadium, tungsten and molybdenum on inhibition of glucose formation in renal tubules and hepatocytes of control and diabetic rabbits: beneficial action of melatonin and N-acetylcysteine. Mol. Cell. Biochem. 261 (2004) 9-21
48. Kiersztan A., Lukasinska I., Baranska A., Lebiedzinska M., Nagalski A., Derlacz R.A., and Bryla J. Differential effects of selenium compounds on glucose synthesis in rabbit kidney-cortex tubules and hepatocytes. In vitro and in vivo studies. J. Inorg. Biochem. 101 (2007) 493-505
49. Drozak J., Kozlowski M., Doroszewska R., Pera L., Derlacz R., Jarzyna R., and Bryla J. Differential effects of selegiline on glucose synthesis in rabbit kidney-cortex tubules and hepatocytes. In vitro and in vivo studies. Chem. Biol. Interact. 170 (2007) 162-176
50. Drozak J., Miecznik A., Jarzyna R., and Bryla J. The inhibition of gluconeogenesis by gatifloxacin may contribute to its hypoglycaemic action. Eur. J. Pharmacol. (2008) [Epub ahead of print]
51. Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei. Med. J. 45 (2004) 776-788
52. Obrosova I.G., and Stevens M.J. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens. Invest. Ophthalmol. Vis. Sci. 40 (1999) 680-688
53. Patriarca S., Furfaro A.L., Domenicotti C., Odetti P., Cottalasso D., Marinari U.M., Pronzato M.A., and Traverso N. Supplementation with N-acetylcysteine and taurine failed to restore glutathione content in liver of streptozotocin-induced diabetics rats but protected from oxidative stress. Biochim. Biophys. Acta. 1741 (2005) 48-54
54. Winiarska K., Fraczyk T., Malinska D., Drozak J., and Bryla J. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J. Pineal. Res. 40 (2006) 168-176
55. Tas S., Sarandol E., Ayvalik S.Z., Serdar Z., and Dirican M. Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems. Arch. Med. Res. 38 (2007) 276-283
56. Lim E., Park S., and Kim H. Effect of taurine supplementation on the lipid peroxide formation and the activities of glutathione-related enzymes in the liver and islet of type I and II diabetic model mice. Adv. Exp. Med. Biol. 442 (1998) 99-103
57. Gurujeyalakshmi G., Wang Y., and Giri S.N. Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice. J. Pharmacol. Exp. Ther. 293 (2000) 82-90
58. Maher S.G., Condron C.E., Bouchier-Hayes D.J., and Toomey D.M. Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD). Clin. Exp. Immunol. 139 (2005) 279-286
59. Reusens B., Sparre T., Kalbe L., Bouckenooghe T., Theys N., Kruhøffer M., Orntoft T.F., Nerup J., and Remacle C. The intrauterine metabolic environment modulates the gene expression pattern in fetal rat islets: prevention by maternal taurine supplementation. Diabetologia 51 (2008) 36-45
60. Rodriguez C., Mayo J.C., Sainz R.M., Antolín I., Herrera F., Martín V., and Reiter R.J. Regulation of antioxidant enzymes: a significant role for melatonin. J. Pineal. Res. 36 (2004) 1-9
61. Ha H., Yu M.R., and Kim K.H. Melatonin and taurine reduce early glomerulopathy in diabetic rats. Free. Radic. Biol. Med. 26 (1999) 944-950
62. Verzola D., Bertolotto M.B., Villaggio B., Ottonello L., Dallegri F., Frumento G., Berruti V., Gandolfo M.T., Garibotto G., and Deferran G. Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. J. Investig. Med. 50 (2002) 443-451
63. Koya D., Hayashi K., Kitada M., Kashiwagi A., Kikkawa R., and Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J. Am. Soc. Nephrol. 14 (2003) S250-S253
64. Mozaffari M.S., Miyata N., and Schaffer S.W. Effects of taurine and enalapril on kidney function of the hypertensive glucose-intolerant rat. Am. J. Hypertens. 16 (2003) 673-680
65. Odetti P., Pesce C., Traverso N., Menini S., Maineri E.P., Cosso L., Valentini S., Patriarca S., Cottalasso D., Marinari U.M., and Pronzato M.A. Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes 52 (2003) 499-505
66. Obrosova I.G., Fathallah L., and Stevens M.J. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp. Neurol. 172 (2001) 211-219
67. Di Leo M.A., Ghirlanda G., Gentiloni Silveri N., Giardina B., Franconi F., and Santini S.A. Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementations. Free. Radic. Res. 37 (2003) 323-330
68. Casey R.G., Gang C., Joyce M., and Bouchier-Hayes D.J. Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction. J. Vasc. Res. 44 (2007) 31-39
69. Ulrich-Merzenich G., Zeitler H., Vetter H., and Bhonde R.R. Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins. Eur. J. Nutr. 46 (2007) 431-438
70. Abebe W. Effects of taurine on the reactivity of aortas from diabetic rats. Life. Sci. 82 (2008) 279-289
71. Etoh T., Inoguchi T., Kakimoto M., Sonoda N., Kobayashi K., Kuroda J., Sumimoto H., and Nawata H. Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia 46 (2003) 1428-1437
72. Oshiro Y., Ma R.C., Yasuda Y., Hiraoka-Yamamoto J., Clermont A.C., Isshiki K., Arikawa E., Kern T.S., and King G.L. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Diabetes 55 (2006) 3112-3120
73. Asaba K., Tojo A., Onozato M.L., Goto A., Quinn M.T., Fujita T., and Wilcox C.S. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney. Int. 67 (2005) 1890-1898